Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Humoral Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableStudy completedNCT01771367
What this trial is testing

Training Study to Characterize Biomarkers to Flu Vaccines

Who this might be right for
Healthy
University of Surrey 49
Not applicableStudy completedNCT04355338
What this trial is testing

Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA)

Who this might be right for
COVID-19
Butantan Institute 3,520
Early research (Phase 1)Study completedNCT01489358
What this trial is testing

Chikungunya Virus Vaccine Trial in Healthy Adults

Who this might be right for
Viral VaccinesChikungunya FeverChikungunya Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04745559
What this trial is testing

Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

Who this might be right for
Diffuse Large-Cell LymphomaPrimary Mediastinal Large B-Cell Lymphoma (PMBCL)Transformed Follicular Lymphoma (TFL)+2 more
H. Lee Moffitt Cancer Center and Research Institute 26
Early research (Phase 1)Study completedNCT01386489
What this trial is testing

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

Who this might be right for
HIV NegativeAdaptive ImmunityInnate Immunity
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT03111589
What this trial is testing

Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.

Who this might be right for
Sickle Cell Disease
Francis Corazza 102
Post-approval studies (Phase 4)Ended earlyNCT02485639
What this trial is testing

Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT00005571
What this trial is testing

Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis

Who this might be right for
Dermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 17
Not applicableStudy completedNCT03098862
What this trial is testing

PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,830
Not applicableStudy completedNCT03613636
What this trial is testing

Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)

Who this might be right for
Childhood PneumoniaMycoplasma PneumoniaAntibody-secreting Cells+2 more
University Children's Hospital, Zurich 490
Post-approval studies (Phase 4)Study completedNCT01148667
What this trial is testing

Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity

Who this might be right for
Gut MicrobiotaSkin MicrobiotaHumoral Immune Responses+1 more
Turku University Hospital 40